TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: Finally, among the top KEGG pathways identified were the p53 signaling pathway, renal cell carcinoma, miRNAs in cancer, chronic myeloid leukemia, platinum drug resistance, and cell cycle (Figure 2b).